US Edition
Medtronic’s MiniMed 780G System Gains CE Mark for Expanded Indications
Summary by Medical Device Network
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Medtronic MiniMed 780G wins CE mark for type 2 diabetes
The MiniMed 780G automated insulin delivery system with the Simplera Sync CGM. [Image courtesy of Medtronic]Medtronic (NYSE:MDT) announced today that it received CE mark to expand its MiniMed 780G’s indications, including for type 2 diabetes. The expansion brings the automated insulin delivery (AID) system to individuals aged two years and older with type 1 diabetes. It also enables the use of MiniMed 780G during pregnancy and by those with type…
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
